Prompt treatment of disseminated HSV-2 infection in a patient with compromised cellular immunity: A case of aborted hemophagocytic lymphohistiocytosis?

Antonios Tsimpidakis; Dimitrios Tsilingiris; Eleni Remountaki; Eftychia Zouridaki; Dimitrios Rigopoulos; Electra Nicolaidou

doi:10.1002/ccr3.2961

Prompt treatment of disseminated HSV-2 infection in a patient with compromised cellular immunity: A case of aborted hemophagocytic lymphohistiocytosis?

Clin Case Rep. 2020 May 25;8(9):1628-1630. doi: 10.1002/ccr3.2961. eCollection 2020 Sep.

Authors

Antonios Tsimpidakis¹, Dimitrios Tsilingiris², Eleni Remountaki¹, Eftychia Zouridaki¹, Dimitrios Rigopoulos¹, Electra Nicolaidou¹

Affiliations

¹ 1st Department of Dermatology and Venereology National and Kapodistrian University of Athens School of Medicine "Andreas Syggros" Hospital for Skin and Venereal Diseases Athens Greece.
² 1st Department of Propaedeutic Internal Medicine National and Kapodistrian University of Athens School of Medicine "Laiko" General Hospital Athens Greece.

Abstract

Recognition of unusual manifestations such as disseminated HSV or HSV-related hemophagocytic lymphohistiocytosis among individuals with impaired cellular immunity and prompt treatment initiation are essential for a favorable outcome.

Keywords: disseminated HSV‐2; fingolimod; hemophagocytic lymphohistiocytosis; herpes simplex virus type 2.

Publication types

Case Reports